435 related articles for article (PubMed ID: 27080129)
1. Manifestation of Huntington's disease pathology in human induced pluripotent stem cell-derived neurons.
Nekrasov ED; Vigont VA; Klyushnikov SA; Lebedeva OS; Vassina EM; Bogomazova AN; Chestkov IV; Semashko TA; Kiseleva E; Suldina LA; Bobrovsky PA; Zimina OA; Ryazantseva MA; Skopin AY; Illarioshkin SN; Kaznacheyeva EV; Lagarkova MA; Kiselev SL
Mol Neurodegener; 2016 Apr; 11():27. PubMed ID: 27080129
[TBL] [Abstract][Full Text] [Related]
2. Human-to-mouse prion-like propagation of mutant huntingtin protein.
Jeon I; Cicchetti F; Cisbani G; Lee S; Li E; Bae J; Lee N; Li L; Im W; Kim M; Kim HS; Oh SH; Kim TA; Ko JJ; Aubé B; Oueslati A; Kim YJ; Song J
Acta Neuropathol; 2016 Oct; 132(4):577-92. PubMed ID: 27221146
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Store-Operated Calcium Entry Leads to Striatal Synaptic Loss in a Huntington's Disease Mouse Model.
Wu J; Ryskamp DA; Liang X; Egorova P; Zakharova O; Hung G; Bezprozvanny I
J Neurosci; 2016 Jan; 36(1):125-41. PubMed ID: 26740655
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis of induced pluripotent stem cells derived from a human Huntington's disease patient.
Chae JI; Kim DW; Lee N; Jeon YJ; Jeon I; Kwon J; Kim J; Soh Y; Lee DS; Seo KS; Choi NJ; Park BC; Kang SH; Ryu J; Oh SH; Shin DA; Lee DR; Do JT; Park IH; Daley GQ; Song J
Biochem J; 2012 Sep; 446(3):359-71. PubMed ID: 22694310
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cell lines from Huntington's disease mice undergo neuronal differentiation while showing alterations in the lysosomal pathway.
Castiglioni V; Onorati M; Rochon C; Cattaneo E
Neurobiol Dis; 2012 Apr; 46(1):30-40. PubMed ID: 22227000
[TBL] [Abstract][Full Text] [Related]
6. STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease.
Vigont VA; Grekhnev DA; Lebedeva OS; Gusev KO; Volovikov EA; Skopin AY; Bogomazova AN; Shuvalova LD; Zubkova OA; Khomyakova EA; Glushankova LN; Klyushnikov SA; Illarioshkin SN; Lagarkova MA; Kaznacheyeva EV
Front Cell Dev Biol; 2021; 9():625231. PubMed ID: 33604336
[TBL] [Abstract][Full Text] [Related]
7. Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.
Juopperi TA; Kim WR; Chiang CH; Yu H; Margolis RL; Ross CA; Ming GL; Song H
Mol Brain; 2012 May; 5():17. PubMed ID: 22613578
[TBL] [Abstract][Full Text] [Related]
8. Amelioration of Huntington's disease phenotype in astrocytes derived from iPSC-derived neural progenitor cells of Huntington's disease monkeys.
Cho IK; Yang B; Forest C; Qian L; Chan AWS
PLoS One; 2019; 14(3):e0214156. PubMed ID: 30897183
[TBL] [Abstract][Full Text] [Related]
9. Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.
Liu L; Huang JS; Han C; Zhang GX; Xu XY; Shen Y; Li J; Jiang HY; Lin ZC; Xiong N; Wang T
Mol Neurobiol; 2016 Dec; 53(10):6698-6708. PubMed ID: 26659595
[TBL] [Abstract][Full Text] [Related]
10. Energy Metabolism and Mitochondrial Superoxide Anion Production in Pre-symptomatic Striatal Neurons Derived from Human-Induced Pluripotent Stem Cells Expressing Mutant Huntingtin.
Hamilton J; Brustovetsky T; Sridhar A; Pan Y; Cummins TR; Meyer JS; Brustovetsky N
Mol Neurobiol; 2020 Feb; 57(2):668-684. PubMed ID: 31435904
[TBL] [Abstract][Full Text] [Related]
11. Patient-Specific iPSC-Based Models of Huntington's Disease as a Tool to Study Store-Operated Calcium Entry Drug Targeting.
Vigont V; Nekrasov E; Shalygin A; Gusev K; Klushnikov S; Illarioshkin S; Lagarkova M; Kiselev SL; Kaznacheyeva E
Front Pharmacol; 2018; 9():696. PubMed ID: 30008670
[TBL] [Abstract][Full Text] [Related]
12. Derivation of Huntington's disease-affected human embryonic stem cell lines.
Bradley CK; Scott HA; Chami O; Peura TT; Dumevska B; Schmidt U; Stojanov T
Stem Cells Dev; 2011 Mar; 20(3):495-502. PubMed ID: 20649476
[TBL] [Abstract][Full Text] [Related]
13. RTP801 Is Involved in Mutant Huntingtin-Induced Cell Death.
Martín-Flores N; Romaní-Aumedes J; Rué L; Canal M; Sanders P; Straccia M; Allen ND; Alberch J; Canals JM; Pérez-Navarro E; Malagelada C
Mol Neurobiol; 2016 Jul; 53(5):2857-2868. PubMed ID: 25876513
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the role of the A2A adenosine receptor in neurodegeneration using neurons derived from Huntington's disease iPSCs.
Chiu FL; Lin JT; Chuang CY; Chien T; Chen CM; Chen KH; Hsiao HY; Lin YS; Chern Y; Kuo HC
Hum Mol Genet; 2015 Nov; 24(21):6066-79. PubMed ID: 26264576
[TBL] [Abstract][Full Text] [Related]
15. FOXOs modulate proteasome activity in human-induced pluripotent stem cells of Huntington's disease and their derived neural cells.
Liu Y; Qiao F; Leiferman PC; Ross A; Schlenker EH; Wang H
Hum Mol Genet; 2017 Nov; 26(22):4416-4428. PubMed ID: 28973411
[TBL] [Abstract][Full Text] [Related]
16. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
17. Molecular Components of Store-Operated Calcium Channels in the Regulation of Neural Stem Cell Physiology, Neurogenesis, and the Pathology of Huntington's Disease.
Latoszek E; Czeredys M
Front Cell Dev Biol; 2021; 9():657337. PubMed ID: 33869222
[TBL] [Abstract][Full Text] [Related]
18. Progerin-Induced Transcriptional Changes in Huntington's Disease Human Pluripotent Stem Cell-Derived Neurons.
Cohen-Carmon D; Sorek M; Lerner V; Divya MS; Nissim-Rafinia M; Yarom Y; Meshorer E
Mol Neurobiol; 2020 Mar; 57(3):1768-1777. PubMed ID: 31834602
[TBL] [Abstract][Full Text] [Related]
19. Dysregulation of Neuronal Calcium Signaling via Store-Operated Channels in Huntington's Disease.
Czeredys M
Front Cell Dev Biol; 2020; 8():611735. PubMed ID: 33425919
[TBL] [Abstract][Full Text] [Related]
20. Cellular Models: HD Patient-Derived Pluripotent Stem Cells.
Geater C; Hernandez S; Thompson L; Mattis VB
Methods Mol Biol; 2018; 1780():41-73. PubMed ID: 29856014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]